Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Lupus Erythematosus, Systemic 1Infectious Mononucleosis 1Infections 1Fatigue Syndrome, Chronic 1Epstein-Barr Virus Infections 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 9Ciprofloxacin 8Voriconazole 5Vancomycin 4Caspofungin 4Amoxicillin-Potassium Clavulanate Combination 4gamma-Globulins 3Fluconazole 3Filgrastim 3Daptomycin 3Antibiotic Prophylaxis 3plerixafor 2liposomal amphotericin B 2Whole-Body Irradiation 2Trimethoprim 2Therapeutics 2Sulfamethoxazole 2Saline Solution 2Rituximab 2Ribavirin 2Polymerase Chain Reaction 2Piperacillin, Tazobactam Drug Combination 2Peripheral Blood Stem Cell Transplantation 2Pentetic Acid 2Moxifloxacin 2Melphalan 2Levofloxacin 2Lenalidomide 2Itraconazole 2Immunoglobulins, Intravenous 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infections × Procalcitonin × Clear all
NCT05127980 2025-02-25

Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection

University Hospital, Basel, Switzerland

Recruiting
80 enrolled

Infections, Infectious Mononucleosis, Lupus Erythematosus, Systemic, Fatigue Syndrome, Chronic, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡